Minapharm Pharmaceuticals

Minapharm is headquartered in Cairo with production facilities in the tenth of Ramadan and is among the leading prescription medicine companies in Egypt and the Middle East. The company is specialized in the manufacture and marketing of innovative specialty pharmaceuticals and through its subsidiary Rhein-Minapharm-Biogenetics, in the research, development and manufacturing of biopharmaceuticals. The biotech subsidiary is focussing on the core therapeutic areas of liver disease and thrombosis & haemostasis. With three therapeutic proteins already marketed and several in the pipeline, Minapharm’s competence lies in decreasing time to market with adherence to the highest international ethical and safety standards. Minapharm employs a collective workforce of over 700 and is listed on the Cairo and Alexandria stock exchange (symbol:MIPH).